To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Nurix Therapeutics by 25,008 shares, the number of shares held increased 1.5% compared to the previous period and now represents 2.44% of the total position.
      148Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 158,064 shares, the number of shares held increased 1.5% compared to the previous period and now represents 1% of the total position.
      269Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Alamar Biosciences by 51,490 shares, the number of shares held increased 5.64% compared to the previous period and now represents 1.5% of the total position.
      54Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Schrodinger Inc. by 30,372 shares, the number of shares held increased 1.5% compared to the previous period and now represents 2.01% of the total position.
      6Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 202,800 shares, the number of shares held increased 1.5% compared to the previous period and now represents 2.59% of the total position.
      5951
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Generate Biomedicines by 18,396 shares, the number of shares held increased 1.5% compared to the previous period and now represents 1.07% of the total position.
      82Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Butterfly Network Inc by 70,932 shares, the number of shares held increased 1.5% compared to the previous period and now represents 2.11% of the total position.
      22Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Intellia Therapeutics by 32,499 shares, the number of shares held decreased 1.12% compared to the previous period and now represents 2.12% of the total position.
      10Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Guardant Health Inc. by 6,768 shares, the number of shares held increased 1.5% compared to the previous period and now represents 4.45% of the total position.
      2Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in GeneDx Holdings by 6,636 shares, the number of shares held increased 1.5% compared to the previous period and now represents 1.74% of the total position.
      21Comment
      Report
       
       
       
       

      Most Discussed